PathogenDx, Zef Scientific partner to offer microbial testing platform
Category: #health  By Paroma Bhattacharya  Date: 2019-07-04
  • share
  • Twitter
  • Facebook
  • LinkedIn

PathogenDx, Zef Scientific partner to offer microbial testing platform

The propriety technology offered by PathogenDx will set a new standard in Canada for testing bacteria

PathogenDx, Inc., a technology company that provides testing solutions to food, agriculture and botanical testing markets, recently announced it has entered into a strategic partnership with Zef Scientific for sales and distribution of microbial testing in Canada.

Under the agreement, both companies aim to grow their accounts nationally, while the partnership has already wrapped up its first account with a testing lab in Canada.

Reportedly, Zef Scientific works with a number of major equipment manufacturers like Shimadzu and take pride in being able to provide laboratories with multi-vendor solutions. The company’s scope ranges from pharmaceutical laboratories to modern cannabis facilities for testing.

Kevork Kalaydjian, Sales Director at Zef Scientific said that the company’s new partnership with PathogenDx will expand their portfolio to include fungal and bacterial testing through PathogenDx’s offered technology, that is unique and DNA-based.

ZefSci is looking forward to offering new line of instrumentation to the Cannabis market in Canada. The proprietary technology offered by PathogenDx will help set a new standard for testing bacteria in the country, a solution that would make sense, Kalaydjian added.

Milan Patel, Co-Founder and CEO of PathogenDx said in an announcement that the partnership and agreement between PathogenDx and Zef Scientific will offer Canadian Cannabis market new access to ultra-fast microbial testing turnaround times. Owing to major regulatory mandates in order to protect recreational consumer safety and patients, the Canadian market has faced certain supply challenges.

The partnership will offer Canadian retailers, regulators, distributors and growers a chance to shorten approval times and testing with greater precision, while also securing safer and better products to market faster for consumers and patients in Canada, Patel mentioned.

Seemingly, molecular technologies are increasingly being adopted by Cannabis testing labs in order to meet the testing mandates for pathogen and avoid relying on culture based methods. Cannabis was legalized for recreational and medicinal use the previous year.

Source Credit- https://www.biospace.com/article/releases/pathogendx-and-zef-scientific-announce-a-strategic-sales-and-service-distribution-partnership-for-microbial-testing-in-canada/



About Author

Paroma Bhattacharya

Email: [email protected]   

Paroma Bhattacharya

Paroma currently works as a content developer for Algosonline, MSF and a series of alike platforms. Fortified with a post-graduation degree in Journalism and Mass Communication, she delved head long into a writing career, creating resourceful and information enriched ...

Read More

More News By Paroma Bhattacharya

Walmart to roll out Delivery Unlimited grocery service across U.S.
Walmart to roll out Delivery Unlimited grocery service across U.S.
By Paroma Bhattacharya

Walmart, the retail giant, recently announced that it is rolling out a new Delivery Unlimited grocery service in 1,400 Walmart stores across U.S. Reportedly, the subscription membership will charge an annual fee of USD...

Amazon gears up for Diwali sale, expands next-day delivery service
Amazon gears up for Diwali sale, expands next-day delivery service
By Paroma Bhattacharya

The firm has increased its overall reach for large appliances to 14,000 pin codes and next-day delivery facilities to over 650 cities.

Amazon.in, the Indian divisio...

4BIO Capital intends to take gene and cell therapies mainstream
4BIO Capital intends to take gene and cell therapies mainstream
By Paroma Bhattacharya

The venture capitalist firm has secured an investment of $50 million and is expecting to gather an investment of up to $150 million till 2020.

4BIO Capital, a Londo...